You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR ANDROGEL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ANDROGEL

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00112151 ↗	TEAM: Testosterone Supplementation and Exercise in Elderly Men	Completed	National Institute on Aging (NIA)	Phase 2	2005-01-01	The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
NCT00112151 ↗	TEAM: Testosterone Supplementation and Exercise in Elderly Men	Completed	University of Colorado, Denver	Phase 2	2005-01-01	The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
NCT00114114 ↗	Dose-Response of Gonadal Steroids and Bone Turnover in Older Men	Completed	AbbVie	N/A	2004-09-01	The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur in older men. This information may help determine when to intervene with hormone replacement therapy in aging men.
NCT00114114 ↗	Dose-Response of Gonadal Steroids and Bone Turnover in Older Men	Completed	AstraZeneca	N/A	2004-09-01	The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur in older men. This information may help determine when to intervene with hormone replacement therapy in aging men.
NCT00114114 ↗	Dose-Response of Gonadal Steroids and Bone Turnover in Older Men	Completed	National Institute on Aging (NIA)	N/A	2004-09-01	The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur in older men. This information may help determine when to intervene with hormone replacement therapy in aging men.
NCT00114114 ↗	Dose-Response of Gonadal Steroids and Bone Turnover in Older Men	Completed	Solvay Pharmaceuticals	N/A	2004-09-01	The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur in older men. This information may help determine when to intervene with hormone replacement therapy in aging men.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ANDROGEL

Condition Name

Chart
Table

Condition Name for ANDROGEL
Intervention	Trials
Hypogonadism	15
Secondary Hypogonadism	5
Obesity	4
Prostate Cancer	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ANDROGEL
Intervention	Trials
Hypogonadism	27
Insulin Resistance	5
Diabetes Mellitus, Type 2	4
Diabetes Mellitus	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ANDROGEL

Trials by Country

Map
Table

Trials by Country for ANDROGEL
Location	Trials
United States	153
Canada	7
Netherlands	4
France	2
Israel	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ANDROGEL
Location	Trials
Texas	13
New York	12
California	12
Washington	9
Florida	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ANDROGEL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ANDROGEL
Clinical Trial Phase	Trials
Phase 4	11
Phase 3	14
Phase 2/Phase 3	1
[disabled in preview]	23
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ANDROGEL
Clinical Trial Phase	Trials
Completed	34
Unknown status	5
Recruiting	5
[disabled in preview]	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ANDROGEL

Sponsor Name

Chart
Table

Sponsor Name for ANDROGEL
Sponsor	Trials
Solvay Pharmaceuticals	11
University of Washington	5
Repros Therapeutics Inc.	5
[disabled in preview]	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ANDROGEL
Sponsor	Trials
Other	56
Industry	33
NIH	9
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.